Vitamin e
As of the edition of 20 October 2026, Vitamin e is a drug: marketed, first approved in 1983 (FR); acts on VDR.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1986
- Kind
- Unknown
- Brand name
- M.V.I.-12 Adult
- First approved
- 21 March 1983 (FR)
- Approvals on record
- 17 in 3 regions
- Holder of the most recent approval
- Pfizer; 9 holders in all
- Registered trials
- 150, 21 stopped early
- Disease areas
- Cancer; Nutrition and metabolism; Digestive system; Urinary and reproductive; Nervous system; Hormones
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| VDR | Vitamin D3 receptor | P11473 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 33 | 15 | 6 | 6 |
| Phase 1 | 17 | 10 | 1 | 1 |
| Phase 2 | 41 | 26 | 5 | 8 |
| Phase 3 | 41 | 25 | 1 | 5 |
| Phase 4 | 18 | 12 | 1 | 1 |
| All trials | 150 |